Kynam Capital Management, LP Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$611.4B
Holdings
28
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANATERA INC | 3,003,668 | $132K | 0.00% | |
| 2 | TCE2CELLDEX THERAPEUTICS INC NEW | 3,200,000 | $88K | 0.00% | |
| 3 | PCVXVAXCYTE INC | 1,302,407 | $66K | 0.00% | |
| 4 | SNDXSYNDAX PHARMACEUTICALS INC | 4,000,000 | $57K | 0.00% | Call |
| 5 | VERAVERA THERAPEUTICS INC | 2,956,053 | $40K | 0.00% | |
| 6 | PTGXPROTAGONIST THERAPEUTICS INC | 1,818,657 | $30K | 0.00% | |
| 7 | TSVT*2SEVENTY BIO INC | 5,953,825 | $23K | 0.00% | |
| 8 | WVEWAVE LIFE SCIENCES LTD | 3,932,082 | $22K | 0.00% | |
| 9 | BCRXBIOCRYST PHARMACEUTICALS INC | 3,133,193 | $22K | 0.00% | |
| 10 | COGTCOGENT BIOSCIENCES INC | 2,210,125 | $21K | 0.00% | |
| 11 | LQDALIQUIDIA CORPORATION | 2,000,000 | $12K | 0.00% | |
| 12 | SLRNACELYRIN INC | 1,200,000 | $12K | 0.00% | |
| 13 | AMRNAMARIN CORP PLC | 12,022,957 | $11K | 0.00% | |
| 14 | TSHATAYSHA GENE THERAPIES INC | 3,281,313 | $10K | 0.00% | |
| 15 | VRDNVIRIDIAN THERAPEUTICS INC | 699,681 | $10K | 0.00% | |
| 16 | TVTXTRAVERE THERAPEUTICS INC | 972,602 | $8K | 0.00% | Call |
| 17 | BNRBURNING ROCK BIOTECH LTD | 8,500,000 | $8K | 0.00% | |
| 18 | DVAXDYNAVAX TECHNOLOGIES CORP | 500,000 | $7K | 0.00% | |
| 19 | STROSUTRO BIOPHARMA INC | 1,552,675 | $5K | 0.00% | |
| 20 | CRBUCARIBOU BIOSCIENCES INC | 1,068,527 | $5K | 0.00% | |
| 21 | CNTACENTESSA PHARMACEUTICALS PLC | 730,472 | $4K | 0.00% | |
| 22 | IMVTIMMUNOVANT INC | 100,000 | $3K | 0.00% | Put |
| 23 | OLMAOLEMA PHARMACEUTICALS INC | 235,176 | $2K | 0.00% | |
| 24 | PBYIPUMA BIOTECHNOLOGY INC | 473,975 | $1K | 0.00% | |
| 25 | GOSSGOSSAMER BIO INC | 250,000 | $0 | 0.00% | |
| 26 | CNTBCONNECT BIOPHARMA HLDGS LTD | 535,005 | $0 | 0.00% | |
| 27 | —NEOLEUKIN THERAPEUTICS INC | 24,037 | $0 | 0.00% | |
| 28 | GYRECATALYST BIOSCIENCES INC | 90,058 | $0 | 0.00% |